Article
Endeavor BioMedicines raises $62 million to combat pulmonary disease – TechCrunch
Rating:
0.0
Views:
52
Likes:
1
Library:
1
A new startup has officially emerged from stealth with the raise of its $62 million Series A funding round. Endeavor BioMedicines is led by co-founder and CEO John Hood, who previously led Impact Biomedicines, and its new funding comes from Omega Funds and Longitude Capital, as well as the company&…
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value